TrialThe Pediatric infectious disease journal2020

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2-9 Years of Age: A Phase III, Randomized Study.

Carmen I Baccarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.